Cerebellum’s Oracle ORCL Stock Holding History

Cerebellum’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,655	Closed	-$126K	–	525
2020 Q2	$126K	Buy	+2,655	New	+$141K	0.09%	238
2019 Q4	$530K	Buy	+9,996	New	+$550K	0.28%	256
2018 Q1	–	Sell	-2,655	Closed	-$126K	–	512
2017 Q4	$126K	Buy	+2,655	New	+$130K	0.09%	238

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cerebellum's ORCL Position: Q3 2020 in Review

Cerebellum sold out of Oracle (ORCL) in Q3 2020, closing a stake of 2,655 shares — an estimated $126K sold.

Cerebellum first reported a position in ORCL in Q4 2017 and held it in 3 quarters. The position peaked at $530K in Q4 2019. 1,870 funds tracked by Wall St. Rank hold ORCL as of Q3 2020.

Cerebellum reported no remaining Oracle position as of Q3 2020 after selling out during the quarter.
Cerebellum sold 2,655 Oracle shares in Q3 2020, an estimated $126K.
Cerebellum first reported a position in Oracle in Q4 2017 and held it in 3 quarters.
Cerebellum's Oracle position peaked at $530K in Q4 2019.
1,870 funds tracked by Wall St. Rank held Oracle as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.